Congress is out of session until Monday, November 9 for the midterm campaign. No new roll-call votes until then; the last were the House on Sep 16 and the Senate on Sep 30.

S. 1133 · 118th Congress · Health

340B Accountability Act of 2023

Died in committee133 words Introduced Mar 30, 2023 · Latest action Mar 30, 2023

FollowRead the text
How far it has goneStopped at 2 of 6 · Died in committee
  1. IntroducedMar 30, 2023 Done
  2. CommitteeDied Jan 3, 2025 Stopped here
  3. Senate floorNot yet Not reached yet
  4. House floorNot yet Not reached yet
  5. Chambers agreeNot yet Not reached yet
  6. PresidentNot yet Not reached yet

What it does

This bill requires participants in the 340B drug pricing program to allow the Health Resources & Services Administration (HRSA) to audit their records to determine how they use the net income from the discounted drug prices under the program. Participants also must retain records and reports as necessary for HRSA to perform the audits.

Congressional Research Service · summary of “Introduced in Senate” version · Mar 30, 2023

Who lobbies on it

4 organizations · 14 filings · Q1 2023–Q4 2024

One square per quarter since introduction, oldest left. Filled = named it that quarter.

  1. 340b Health 6 of 8 quarters
    “The 340B Drug Pricing Program; H.R. 2534, The Protect 340B Act; FY24 and FY25 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations bills. HR 3290,to amend title III of the Public Health Service Act to ensure transparency and oversight of the 340B drug discount program.…”

    Q4 2024 filing · $1.3M lobbying spend in 2024, all issues

  2. Novartis 4 of 8 quarters
    “S. 1133: 340B Accountability Act 340B Drug Discount Program - Program Implementation & Oversight H.R 2534 - PROTECT 340B Act S. 5021/HR. 7635 - 340B PATIENTS Act of 2024 340B Drug Discount Program - RFI for SUSTAIN 340B Act H.R. 2408: Access to Innovative Treatments Act of 2023 HR. 8574: 340B Affording Care for…”

    Q4 2024 filing · $6.0M lobbying spend in 2024, all issues

  3. Vizient Inc 3 of 8 quarters
    “Hospital Group Purchasing - Advocated to highlight the value that hospital group purchasing organizations provide to hospitals and suppliers. Provided education on how GPOs work in the healthcare supply chain and the role they play in delivering value to healthcare providers. Endorsed passage of Connecting Our Medical…”

    Q4 2023 filing · $1.7M lobbying spend in 2023, all issues

1 more organization, every filingPROUpgrade

Organizations that named S. 1133 in a quarterly lobbying report. Covers organizations with a PAC on file; reports from organizations without one aren’t loaded yet. Spend is the organization’s total across all issues: reports don’t split spending by bill. Source: Senate lobbying disclosures (LD-2) from lda.gov; quotes are word for word from the “specific lobbying issues” field.

Actions

2 actions · newest first
  1. Mar 30, 2023Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
  2. Mar 30, 2023Introduced in Senate